Do GPs treat patients with gastro-oesophageal reflux optimally? What are the benefits of a multi-disciplinary approach?
Mr Nick Boyle

The prevalence of Gastro-oesophageal disease (GORD) is high - perhaps 20-30% of the adult population will experience reflux symptoms on a regular and frequent basis. Those with severe symptoms can experience an impact on their quality of life equivalent to patients with life threatening conditions. In the UK alone over half a million people are prescribed PPIs on a regular basis and the annual cost of these drugs amounts to more than £500M. And yet treatment of these patients is often inadequate.

Studies have shown than that of those treated medically 20-30% experience frequent break-through symptoms. Many of these patients are not considered for surgery and those that are often are investigated inadequately or treated in low volume centres. This, despite the published evidence that surgery can offer better outcomes than best medical treatments. Furthermore, over recent years it has become increasingly recognised that the majority of patients with GORD do not experience classical "intestinal" dyspeptic type symptoms but rather other manifestations including respiratory or ENT type symptoms. These often go undiagnosed.

Finally, new technologies have been introduced in recent years offering novel investigation and treatment options. These now allow for instance the diagnosis of patients with non-acidic reflux and offer minimally invasive surgical options with potentially fewer side effects than traditional procedures.

This video has been sponsored by Torax Medical Inc.

For further information on The LINX® Reflux Management System please visit the Torax Medical website

The views expressed in this presentation are those of the speakers and not necessarily of OmniaMed Ltd or its associates.